Healthcare

❤️ New ACC/AHA guidelines recommend cardiovascular screening starting at age nine and statin consideration at 30, with evolocumab cutting first heart attacks by 31 percent in diabetes patients. 🤖 Eli Lilly's $2.75 billion deal with Insilico Medicine marks the largest AI drug discovery partnership ever, as over 173 AI-discovered drugs advance through clinical trials toward the first potential FDA approval. 🦠 A gut bacteria compound called Bac429 doubled cancer immunotherapy response in resistant lung tumors and is now being prepared for human testing. 😴 A study of nearly 39,000 adults proved that combining morning sunlight, time-restricted eating, Zone 2 exercise, and five minutes of breathwork significantly improves sleep, fitness, and nervous system resilience. ⛰️ Multi-biomarker wearables combining glucose, heart, temperature, and activity sensing are launching in 2026, while the first needle-free CGM has received FDA clearance.

🧬 Epigenetic reprogramming has entered human trials — Life Biosciences is now enrolling patients in the first FDA-cleared age-reversal study. 🧠 Two major Alzheimer's breakthroughs this week — a newly identified "death switch" molecule and CAR-astrocyte plaque cleaners. 🤖 AI co-scientists are validating drug discoveries in real time — Google's system confirmed AML drug candidates; NVIDIA + Lilly committed $1B to the space. 🦠 A single gut bacteria molecule doubled cancer immunotherapy response — Bac429 is moving toward human drug development. 😴 Sleep is about daytime function, not just nighttime hours — a new clinical framework is changing how insomnia is measured and treated.

Your daily briefing on the latest breakthroughs in longevity science, health technology, and lifestyle optimization — curated from the world's top research institutions.